Access cutting-edge chronic inflammatory demyelinating polyradiculoneuropathy treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Rochester location
Access chronic inflammatory demyelinating polyradiculoneuropathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic inflammatory demyelinating polyradiculoneuropathy treatment provided free
Check if you qualify for this chronic inflammatory demyelinating polyradiculoneuropathy clinical trial in Rochester, MN
No-Cost Study Care
Local to Rochester
Convenient for MN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
CIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over time, these nerves lose their ability to send signals to the muscles in the body. This leads to muscle weakness and loss of sensation in arms and legs among other symptoms. Participants with CIDP can be treated with a protein called immunoglobulin (or IG). TAK-411 is a special type of immune globu
Sponsor: Takeda
Yes, this clinical trial (NCT06798012) has an active research site in Rochester, MN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic inflammatory demyelinating polyradiculoneuropathy treatment options in Rochester, MN, this clinical trial (NCT06798012) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyradiculoneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic inflammatory demyelinating polyradiculoneuropathy clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Rochester — not just this study.
Browse Multiple Myeloma Trials in Rochester →